Clavelli Victor M 4
4 · OptiNose, Inc. · Filed Mar 8, 2021
Insider Transaction Report
Form 4
OptiNose, Inc.OPTN
Clavelli Victor M
Chief Commercial Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-03-04$3.51/sh+80,000$280,800→ 80,000 totalExercise: $3.51Exp: 2031-03-04→ Common Stock (80,000 underlying) - Award
Common Stock
2021-03-04+53,333→ 53,333 total
Footnotes (2)
- [F1]Represents the grant of restricted stock units (RSUs). Twenty-five percent (25%) of the RSUs vest on March 15, 2022, and the balance vests in equal quarterly installments over the remaining three years of the four-year period, subject to continued service with the Issuer. Each RSU represents the right to receive one share of common stock of OptiNose, Inc.
- [F2]The option vests and becomes exercisable over a four-year period commencing on March 4, 2021. Twenty-five percent (25%) of the option vests and becomes exercisable on March 4, 2022, and the balance vests in equal monthly installments (rounded down to the nearest whole share) over the remaining three years of the four-year period, subject to continued service with the Issuer.